Floatz logo

BENZTROPINE

Bipolar Disorder

University of PittsburghSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

49 Active assets in the Bipolar Disorder cohort.

Asset / SponsorPhaseRating
Asenapine
Dr. Stavroula Rakitzi
Phase 4BBB
Cipralex
First Affiliated Hospital of Zhejiang University
Phase 4BBB
CITALOPRAM
University of Texas Southwestern Medical Center
Phase 4BBB
Seroquel®
First Affiliated Hospital of Zhejiang University
Phase 4BBB
LAMOTRIGINE
Johns Hopkins University
Phase 4BBB

View all 50 →

Same molecule, other indications

BENZTROPINE is also rated in:

schizoaffective disorderDormant
B
Indicative ·
63 / 100
View asset →
vertebral column disorderDormant
B
Indicative ·
61 / 100
View asset →
schizophreniaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →